Efficacy and Safety of COVID-19 Vaccines in Children

Video

Sean O’Leary, MD, discusses the importance of protection against severe disease vs infection of COVID-19, as well as safety considerations of COVID-19 vaccines in the pediatric population.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Tina Tan, MD
Karen Y. Capusan, DNP, CPNP-PC
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Tina Tan, MD
Robert Frenck, MD
Robert Frenck, MD
Related Content
ACIP updates: Committee votes 5-2 to recommend clesrovimab to protect against RSV | Image Credit: © JJHVEPhoto - © JHVEPhoto - stock.adobe.com.

ACIP updates: Committee recommends clesrovimab for RSV, reaffirms routine influenza vaccination

Joshua Fitch, Senior Editor
June 26th 2025
Article

The final recommendation sign off decision will go to HHS secretary Robert F. Kennedy Jr.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD

Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD

Octavio Ramilo, MD
June 20th 2025
Article

Octavio Ramilo, MD, joins us once again to discuss potential benefits of RSV vaccination beyond disease prevention, and to explain how to speak with patients about vaccines and uptake.

Addressing parental concerns about the COVID-19 vaccine

Addressing parental concerns about the COVID-19 vaccine

Miranda Hester
May 14th 2021
Podcast

Contemporary Pediatrics sat down with Dr. Donna Hallas to discuss how to communicate with parents as well as how to address vaccines missed because of the pandemic.

Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years | Image Credit: © ImageKing - © ImageKing - stock.adobe.com.

Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years

Joshua Fitch, Senior Editor
June 13th 2025
Article

Currently, Vimkunya is FDA-approved for use among individuals aged 12 years and older.

Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels | Image Credit: © Monir - © Monir - stock.adobe.com.

Six-month IXCHIQ chikungunya vaccine data demonstrates sustained antibody levels

Joshua Fitch, Senior Editor
June 5th 2025
Article

Six-month results from the phase 2 VLA1553-221 trial aligned with initial data and demonstrated immune response at day 180 among patients aged 1 to 11 years.

© 2025 MJH Life Sciences

All rights reserved.